24.08.2010 • NewsBHP BillitonfertilizerPotash

Potash Holds Talks With Sinochem

Potash has held discussions with China's Sinochem, said a source close to the matter on Monday, as the Canadian fertilizer producer looks for options to BHP Billiton's $38.6 billion hostile bid.

"One wants to explore all the options and you can't do that by telekinesis," said the source, who asked not to be named. Separately, a second source confirmed that Potash was considering joint ventures with third parties as one possible option.

Earlier on Monday, Bloomberg, citing a person with knowledge of the matter, said Sinochem, as well as Brazil's Vale, had made inquiries with the board of Potash late last week about the possibility of talks.

Potash declined to comment. A Sinochem official did not have any knowledge of the reported contact with Potash. Vale had no comment.

In a statement issued on Monday, Potash said it has been approached by, and has initiated contact with, a number of third parties who have expressed an interest in considering alternative transactions.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.